You are using an older browser version. Please use a supported version for the best MSN experience.

Oxford vaccine ready for Phase 2, 3 trials in India with revised protocol

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed COVID-19 vaccine candidate in the country. According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites. Watch the video for more.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon